Marketplace

Marketplace

1-20 of 76 results
1 2 3 4

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

Sep 27, 2022 by
GLOBE NEWSWIRE

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

Sep 23, 2022
BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

Sep 23, 2022
BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

Sep 17, 2022
Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Sep 15, 2022 by
PRNewswire

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Sep 15, 2022 by
GLOBE NEWSWIRE

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Sep 06, 2022 by
PRNewswire

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Teleflex awarded Central Venous Access contract from Vizient

Aug 01, 2022
Teleflex awarded Central Venous Access contract from Vizient

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension

Jul 26, 2022
ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension

First and Only Peripheral Tri-axial 4-French Low-Profile Self-Expanding Stent System Receives FDA Approval

Jul 26, 2022
First and Only Peripheral Tri-axial 4-French Low-Profile Self-Expanding Stent System Receives FDA Approval

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

Jul 12, 2022 by
PRNewswire

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

Jul 06, 2022 by
BUELACH, Switzerland

New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

Jul 05, 2022 by
Orchestra BioMed

Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO-RESORT Small Vessels Subgroup Analysis

Jul 05, 2022
Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO-RESORT Small Vessels Subgroup Analysis

Best Medical International Recognizes Early Research Efforts and the Advent of Vascular Brachytherapy 30 Years Ago

Jun 28, 2022 by
EINPresswire.com

Best Medical International Recognizes Early Research Efforts and the Advent of Vascular Brachytherapy 30 Years Ago

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

Jun 22, 2022 by
PRNewswire

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

Jun 22, 2022 by
GLOBE NEWSWIRE

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

Jun 20, 2022 by
PRNewswire

SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Jun 15, 2022 by
PRNewswire

Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Medtronic low-profile drug-coated balloon platform receives U.S. FDA approval to treat peripheral arterial disease

May 27, 2022
Medtronic low-profile drug-coated balloon platform receives U.S. FDA approval to treat peripheral arterial disease

1-20 of 76 results
1 2 3 4

CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Refine Your Results

Search

Track

Type

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Teleflex awarded Central Venous Access contract from Vizient

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension

First and Only Peripheral Tri-axial 4-French Low-Profile Self-Expanding Stent System Receives FDA Approval

Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO-RESORT Small Vessels Subgroup Analysis

Best Medical International Recognizes Early Research Efforts and the Advent of Vascular Brachytherapy 30 Years Ago

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Medtronic low-profile drug-coated balloon platform receives U.S. FDA approval to treat peripheral arterial disease

Explore the Site

Stay Connected

Marketplace

Refine Your Results

Search

Track

Type

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected